Boston Harbor Angels
George A. Xixis is a partner in Nutter's Intellectual Property group and a member of the Life Sciences practice group. He focuses his practice on biotechnology, pharmaceuticals and medical devices. George came to Nutter in February 2003 from the AMDeC Foundation, Inc., a consortium of New York-based universities and research hospitals. He previously served as intellectual property counsel at CuraGen Corp., a genomics-based, drug discovery and development company, where he established and oversaw the IP department.
George has particular expertise in the area of short- and long-term strategic planning for growing biopharmaceutical companies. This includes the cost-effective construction of potentially complex IP portfolios, as well as advising on and implementing value maximization strategies, including worldwide litigation and licensing.
George's practice includes all areas of intellectual property, including patents, trademarks, copyrights, and trade secrets, primarily in biotechnology and associated technologies. He has filed and prosecuted patent applications relating to medical devices, protein therapeutics, antibodies, antibody targets, and small molecule targets, as well as diagnostic kits, pioneering platform technologies, business methods and computer software. He has litigated cases, both domestically and internationally, concerning a number of biotechnology and small molecule drugs. He also has extensive experience in transactional IP matters, such as licensing and due diligence, on which he has been published.
George is a member of the American Bar Association, New York State Bar Association and American Psychological Society.
During law school, George was associate managing editor of the Brooklyn Law Review, a member of the Moot Court Honor Society and Philip Jessup International Law Team, and a Richardson Scholar.